Allan Christensen, PhD (he/him/his)

Vipergen, Hovedstaden, Denmark

Dr. Allan Christensen is Director of screening technologies at Vipergen ApS. He has contributed significantly to the development of both Binder Trap Enrichment® and cellular Binder Trap Enrichment® drug discovery technology platforms. He previously worked for LEO Pharma A/S (Ballerup, Denmark) and QSI pharma Aps (Lyngby, Denmark). Dr. Christensen earned his Ph.D. in molecular microbiology from the Technical University of Denmark, in 2002 and his M.Sc. in Biotechnology from the Technical University of Denmark, Denmark in 1998.

Disclosure information not submitted.

Presentation(s):

• Direct identification of molecular glue by screening a DNA-encoded small molecule library inside a living cell

  Wednesday, February 7, 2024
  11:00 AM – 11:30 AM EST